Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Network Comparison Type Rank Value Type description Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 551 to 600 of 16578 in total 
Network Comparison Type: Divided
Value Type: Ranked
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
276\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
20 kda nuclear cap binding protein (ncbp 20 kda subunit) (cbp20) (ncbp interacting protein 1) (nip1). [source:swissprot;acc:p52298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.474\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.939\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04421\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l32. [source:swissprot;acc:p02433]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.969\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10716\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
277\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
267.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.849\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10665\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cln3 protein (battenin) (batten disease protein). [source:swissprot;acc:q13286]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.912\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04408\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
278\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s11. [source:swissprot;acc:p04643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
267.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10642\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
asc-type amino acid transporter 1 (asc-1). [source:swissprot;acc:q9ns82]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.369\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.006\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04398\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
279\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.644\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10605\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional repressor nac1. [source:refseq;acc:nm\_052876]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.309\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04395\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
280\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lbp-9. [source:refseq;acc:nm\_014553]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
210.509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.758\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04394\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metastasis-associated protein mta1. [source:swissprot;acc:q13330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.512\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10578\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
281\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l17 (l23). [source:swissprot;acc:p18621]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
267.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.808\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10557\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.503\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.749\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04392\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
282\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-amylase, salivary precursor (ec 3.2.1.1) (1,4-alpha-d-glucan glucanohydrolase). [source:swissprot;acc:p04745]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
210.498\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.742\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04391\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.297\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10553\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
283\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
267.346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.828\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10552\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upstream binding protein 1 (lbp-1a). [source:refseq;acc:nm\_014517]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04389\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
284\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.235\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.657\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10541\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tankyrase 2 (ec 2.4.2.30) (tank2) (tankyrase ii) (tnks-2) (trf1- interacting ankyrin-related adp-ribose polymerase 2) (tankyrase-like protein) (tankyrase-related protein). [source:swissprot;acc:q9h2k2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.692\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04367\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
285\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.242\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.647\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10532\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 135 kda subunit (tafii-135) (tafii135) (tafii-130) (tafii130). [source:swissprot;acc:o00268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.175\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.354\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04359\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
286\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.633\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1052\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 105 kda subunit (tafii-105) (tafii105) (fragment). [source:swissprot;acc:q92750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.174\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04358\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
287\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, y isoform 2. [source:swissprot;acc:q8td47]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.079\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.758\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10517\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rgs19-interacting protein 1 (gaip c-terminus interacting protein gipc) (rgs-gaip interacting protein) (tax interaction protein 2) (tip-2). [source:swissprot;acc:o14908]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.397\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.132\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04337\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
288\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, x isoform (single copy abundant mrna protein) (scr10). [source:swissprot;acc:p12750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.078\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.758\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10517\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d1 (snrnp core protein d1) (sm-d1) (sm-d autoantigen). [source:swissprot;acc:p13641]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.004\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04314\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
289\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hpaii tiny  fragments locus 9c. [source:refseq;acc:nm\_022727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
246.892\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
272.781\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10486\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04311\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
290\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal-associated transmembrane protein 4 beta; putative integral membrane transporter. [source:refseq;acc:nm\_018407]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
201.325\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04309\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.064\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.969\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10428\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
291\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit beta (nf-y protein chain b) (nf-yb) (ccaat-binding transcription factor subunit a) (cbf-a) (caat- box dna binding protein subunit b). [source:swissprot;acc:p25208]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
228.037\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
251.679\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10368\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pl6 protein (placental protein 6). [source:swissprot;acc:q12893]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.995\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04308\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
292\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15a. [source:swissprot;acc:p39027]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.414\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.411\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10357\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal-associated transmembrane protein 4a (golgi 4-transmembrane spanning transporter mtp). [source:swissprot;acc:q15012]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.995\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04308\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
293\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l23 (l17). [source:swissprot;acc:p23131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.717\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.782\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10356\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.763\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.785\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04301\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
294\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca2 and cdkn1a-interacting protein isoform bccipalpha; brca2 and cdkn1a-interacting protein; cdk inhibitor p21 binding protein; bccipalpha; bccipbeta; tok-1alpha; tok-1beta. [source:refseq;acc:nm\_016567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
265.717\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
240.782\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10356\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
jagged 2 precursor (jagged2) (hj2). [source:swissprot;acc:q9y219]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.715\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04294\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
295\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.423\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.273\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.103\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myocyte-specific enhancer factor 2d. [source:swissprot;acc:q14814]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.709\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.713\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04294\vspace{3pt}}}\\\cline{1-2}\cline{5-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
296\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
jagged 1 precursor (jagged1) (hj1). [source:swissprot;acc:p78504]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
218.714\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l4 isoform a. [source:refseq;acc:nm\_015956]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
266.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
241.282\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10294\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
297\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l7. [source:swissprot;acc:p18124]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
259.984\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.727\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1029\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myocyte-specific enhancer factor 2c. [source:swissprot;acc:q06413]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.709\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.714\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04294\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
298\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calpain 2, large [catalytic] subunit precursor (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (m-type) (m-calpain) (millimolar-calpain) (calpain large polypeptide l2). [source:swissprot;acc:p17655]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.588\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
268.632\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10281\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myocyte-specific enhancer factor 2a (serum response factor-like protein 1). [source:swissprot;acc:q02078]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.715\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04294\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
299\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calpain 1, large [catalytic] subunit (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (mu-type) (mucanp) (micromolar-calpain). [source:swissprot;acc:p07384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
243.592\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
268.635\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10281\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
endoribonuclease dicer (ec 3.1.26.-) (helicase with rnase motif) (helicase-moi). [source:swissprot;acc:q9upy3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.915\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0429\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
300\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
209.669\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04289\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.351\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
150.959\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10196\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/